Zane Ellen M, a director at Boston Scientific Corp ($BSX), sold shares on the open market three times over the past year for a total of $2.57 million. Her latest sale occurred on November 6, 2025. These insider sales rank 2,989th out of 11,678 individuals in our database, trailing the average of $8.6 million per seller and 6.4 transactions. Zane Ellen M recorded no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 883 | $68.02 | 31,426.0000 | 373,900,000 | 2.89% | 0.00% |
| Feb. 17, 2026 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 14 | $72.31 | 30,543.0000 | 373,900,000 | 0.05% | 0.00% |
| Dec. 31, 2025 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 660 | $83.43 | 30,529.0000 | 379,400,000 | 2.21% | 0.00% |
| Nov. 17, 2025 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 15 | $70.47 | 29,869.0000 | 379,400,000 | 0.05% | 0.00% |
| Nov. 6, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Zane Ellen M | Director | S | Common Stock | 12891 | $98.28 | 24,134.0000 | 1,495,500,000 | 34.82% | 0.00% |
| Oct. 29, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Zane Ellen M | Director | J | Common Stock | 12891 | $0.00 | 37,025.0000 | 1,495,500,000 | 53.41% | 0.00% |
| Oct. 27, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Zane Ellen M | Director | S | Common Stock | 9990 | $101.13 | 27,035.0000 | 1,495,500,000 | 26.98% | 0.00% |
| Oct. 28, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Zane Ellen M | Director | S | Common Stock | 2901 | $102.24 | 24,134.0000 | 1,495,500,000 | 10.73% | 0.00% |
| Sept. 30, 2025 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 775 | $71.05 | 29,854.0000 | 400,600,000 | 2.67% | 0.00% |
| Aug. 15, 2025 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 15 | $71.49 | 29,079.0000 | 400,600,000 | 0.05% | 0.00% |
| July 24, 2025 | HAEMONETICS CORP | $HAE | Zane Ellen M | Director | A | Common Stock | 2693 | $0.00 | 19,373.0000 | 50,730,000 | 16.15% | 0.01% |
| June 30, 2025 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 825 | $66.74 | 29,064.0000 | 400,600,000 | 2.92% | 0.00% |
| May 15, 2025 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 17 | $60.49 | 28,239.0000 | 400,600,000 | 0.06% | 0.00% |
| May 8, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Zane Ellen M | Director | A | Common Stock | 2081 | $0.00 | 37,025.0000 | 1,485,900,000 | 5.96% | 0.00% |
| March 31, 2025 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 1039 | $52.94 | 28,222.0000 | 400,600,000 | 3.82% | 0.00% |
| Feb. 24, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Zane Ellen M | Director | S | Common Stock | 13586 | $104.23 | 34,944.0000 | 1,485,900,000 | 28.00% | 0.00% |
| Feb. 18, 2025 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 13 | $65.29 | 27,183.0000 | 400,600,000 | 0.05% | 0.00% |
| Dec. 31, 2024 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 635 | $65.01 | 27,170.0000 | 402,400,000 | 2.39% | 0.00% |
| Nov. 15, 2024 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 15 | $64.98 | 26,535.0000 | 402,400,000 | 0.06% | 0.00% |
| Sept. 30, 2024 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 827 | $49.88 | 26,520.0000 | 423,500,000 | 3.22% | 0.00% |
| Aug. 15, 2024 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 23 | $45.89 | 25,693.0000 | 423,500,000 | 0.09% | 0.00% |
| July 25, 2024 | HAEMONETICS CORP | $HAE | Zane Ellen M | Director | A | Common Stock | 2207 | $0.00 | 16,680.0000 | 51,397,000 | 15.25% | 0.00% |
| June 30, 2024 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 875 | $47.19 | 25,670.0000 | 423,500,000 | 3.53% | 0.00% |
| May 15, 2024 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 26 | $44.14 | 24,795.0000 | 423,500,000 | 0.10% | 0.00% |
| May 9, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Zane Ellen M | Director | A | Common Stock | 2901 | $0.00 | 48,530.0000 | 1,463,500,000 | 6.36% | 0.00% |
| March 31, 2024 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 957 | $43.12 | 24,769.0000 | 423,500,000 | 4.02% | 0.00% |
| Feb. 15, 2024 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Dividend Equivalent Unit | 33 | $39.85 | 23,812.0000 | 423,500,000 | 0.14% | 0.00% |
| Dec. 31, 2023 | Synchrony Financial | $SYF | Zane Ellen M | Director | A | Common Stock | 1081 | $38.19 | 23,779.0000 | 483,400,000 | 4.76% | 0.00% |
| Aug. 8, 2023 | Azenta, Inc. | $AZTA | Zane Ellen M | Director | A | Common Stock | 18766 | $55.78 | 41,134.0000 | 0 | 31.33% | 0.00% |
| Feb. 13, 2023 | Azenta, Inc. | $AZTA | Zane Ellen M | Director | A | Common Stock | 3604 | $0.00 | 59,900.0000 | 0 | 6.40% | 0.00% |